POPULATION KNOWLEDGE AND PERCEPTIONS OF MALARIA VACCINATION AT THE NATIONAL INSTITUTE OF PUBLIC HEALTH (INHP) EXPANDED PROGRAM ON IMMUNIZATION (EPI) UNIT
DOI:
https://doi.org/10.64707/revstss.v49i1.2038Keywords:
Malaria vaccine, clients, EPI unit, uptakeAbstract
Context
In October 2021, WHO recommended the widespread use of RTS,S vaccine as an additional tool in the fight against malaria. To provide guidance on the introduction of this vaccine, we decided to analyse people's knowledge and perceptions of this new vaccine.
Méthods
This was a semi-quantitative cross-sectional descriptive study of clients of the expanded programme on immunisation (EPI) unit of the National Institute of Public Health (INHP). The study was conducted from 1 August 2022 to 30 September 2022. Data was collected through face-to-face interviews using an anonymous questionnaire.
Results
We surveyed a total of 384 clients. The majority of clients, 77.3%, were unaware of the existence of the malaria vaccine. Acceptance of this vaccine was 42.4%, but most (94.3%) were in favour of including it in the EPI. Acceptance of vaccination was correlated with concerns about the vaccine's safety.
Conclusion
Adherence to the RTS,S vaccine was low among clients. This could be explained by fear, concerns and rumours surrounding the introduction of the COVID-19 vaccine in the country. The information generated by this study could help policymakers plan and prioritise the introduction and implementation of malaria vaccination.
Keywords: Malaria vaccine, clients, EPI unit, uptake
References
Organisation mondiale de la Santé. Vaccins antipaludiques (RTS, S et R21) [Internet]. Genève: OMS; [cité 9 août 2024]. Disponible sur: https://www.who.int/fr/news-room/questions-and-answers/item/q-a-on-rts-s-malaria-vaccine
Organisation mondiale de la Santé. Paludisme [Internet]. Genève: OMS; [cité 9 août 2024]. Disponible sur: https://www.who.int/fr/news-room/fact-sheets/detail/malaria
Programme National de Lutte contre le Paludisme (PNLP). Paludisme | le Paludisme en Côte d’Ivoire [Internet]. Abidjan: PNLP; 2020 Avr 20 [cité 9 août 2024]. Disponible sur: https://www.pnlpcotedivoire.org/paludisme-en-cote-d-ivoire/
Organisation mondiale de la Santé | Bureau régional pour l’Afrique. Journée mondiale de lutte contre le paludisme en Côte d’Ivoire : L’OMS encourage le renouvellement de l’engagement politique et la poursuite des investissements dans la prévention et la lutte contre le paludisme [Internet]. Brazzaville: OMS; 2022 [cité 9 août 2024]. Disponible sur: https://www.afro.who.int/fr/countries/cote-divoire/news/journee-mondiale-de-lutte-contre-le-paludisme-en-cote-divoire-loms-encourage-le-renouvellement-de
UNICEF Sénégal. L’acceptabilité des vaccins contre la Covid-19 au sein des communautés au Sénégal [Internet]. Dakar: UNICEF; 2021 [cité 9 août 2024]. Disponible sur: https://www.unicef.org/senegal/rapports/lacceptabilit%C3%A9-des-vaccins-contre-la-covid-19-au-sein-des-communaut%C3%A9s-au-s%C3%A9n%C3%A9gal
Braich JS, Malik SS. Current scenario of malaria vaccine. Int J Basic Clin Pharmacol. 2017;6(2):60–66.
Attoh-Touré H, Adam HE, Bénié BVJ, Tiembré I. Connaissances, opinions et croyances des mères ou accompagnateurs d’enfants dans un centre de vaccination de référence à Abidjan – Côte d’Ivoire. Rev d’épidémiologie Santé Publique. 1 mai 2017;65:S72. DOI: https://doi.org/10.1016/j.respe.2017.03.051
CICG. gouv.ci. RGPH 2021 : les résultats préliminaires estiment à 28 millions l’effectif total de la population résidente permanente en Côte d’Ivoire [Internet]. 2022 [cité 3 oct 2024]. Disponible sur: http://www.gouv.ci/_actualite-article.php?recordID=13247.
Douba A, Aka LB, Yao GH, Zengbe-Acray P, Akani BC, Konan NG. Facteurs sociodémographiques associés à la vaccination incomplète des enfants de 12 à 59 mois dans six pays d’Afrique de l’ouest [Sociodemographic factors associated with incomplete immunization or children aged 12 to 59 months in six West African countries]. Sante Publique. 2015 Sep-Oct;27(5):723-32. French. PMID: 26752038. DOI: https://doi.org/10.3917/spub.155.0723
Asmare G. Willingness to accept malaria vaccine among caregivers of under-5 children in Southwest Ethiopia: a community based cross-sectional study. Malar J. 2022 May 12;21(1):146. doi: 10.1186/s12936-022-04164-z. PMID: 35549710; PMCID: PMC9097094.. DOI: https://doi.org/10.1186/s12936-022-04164-z
Romore I, Ali AM, Semali I, Mshinda H, Tanner M, Abdulla S. Assessment of parental perception of malaria vaccine in Tanzania. Malar J. 2015 Sep 17;14:355. doi: 10.1186/s12936-015-0889-7. PMID: 26383545; PMCID: PMC4573291. DOI: https://doi.org/10.1186/s12936-015-0889-7
Mtenga S, Kimweri A, Romore I, Ali A, Exavery A, Sicuri E, Tanner M, Abdulla S, Lusingu J, Kafuruki S. Stakeholders' opinions and questions regarding the anticipated malaria vaccine in Tanzania. Malar J. 2016 Apr 5;15:189. doi: 10.1186/s12936-016-1209-6. PMID: 27048260; PMCID: PMC4822277.. DOI: https://doi.org/10.1186/s12936-016-1209-6
Chukwuocha UM, Okorie PC, Iwuoha GN, Ibe SN, Dozie IN, Nwoke BE. Awareness, perceptions and intent to comply with the prospective malaria vaccine in parts of South Eastern Nigeria. Malar J. 2018 May 2;17(1):187. doi: 10.1186/s12936-018-2335-0. PMID: 29720172; PMCID: PMC5932831. DOI: https://doi.org/10.1186/s12936-018-2335-0
Yaya Bocoum FI, Kouanda S, Hinson L, Collymore Y, Ba-Nguz A, Bingham A. Perceptions des communautes sur le paludisme et les vaccins : etude qualitative realisee dans les districts sanitaires de Kaya et Hounde, au Burkina Faso [Community perceptions of malaria vaccines : qualitative research from the sanitary districts of Kaya and Hounde in Burkina Faso]. Glob Health Promot. 2014 Mar;21(1):76-87. French. doi: 10.1177/1757975913507729. Epub 2014 Feb 4. PMID: 24496777. DOI: https://doi.org/10.1177/1757975913507729
McCoy KD, Weldon CT, Ansumana R, Lamin JM, Stenger DA, Ryan SJ, Bardosh K, Jacobsen KH, Dinglasan RR. Are malaria transmission-blocking vaccines acceptable to high burden communities? Results from a mixed methods study in Bo, Sierra Leone. Malar J. 2021 Apr 13;20(1):183. doi: 10.1186/s12936-021-03723-0. PMID: 33849572; PMCID: PMC8045381. DOI: https://doi.org/10.1186/s12936-021-03723-0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Sciences de la Santé
This work is licensed under a Creative Commons Attribution 4.0 International License.
